A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

Abstract Objectives • Primary objective: to evaluate the effect of intravenous melatonin (IVM) on mortality in adult patients admitted to the intensive care unit (ICU) with COVID-19. • Secondary objectives: ◦ To evaluate the effect of IVM on ICU length of stay. ◦ To evaluate the effect of IVM on the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miguel Rodríguez-Rubio, Juan Carlos Figueira, Darío Acuña-Castroviejo, Alberto M. Borobia, Germaine Escames, Pedro de la Oliva
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-08-01
Colecção:Trials
Assuntos:
COVID-19
Randomized Controlled Trial
protocol
melatonin
treatment
intensive care
Acesso em linha:http://link.springer.com/article/10.1186/s13063-020-04632-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados